61 results
Page 2 of 4
6-K
EX-99.1
ktunarjudf6cn sl
30 May 23
Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
9:30am
6-K
EX-99.1
ku5rvwjan5ug5x2isu
18 May 23
Inspira™ Technologies Reports First Quarter 2023 Financial Results
4:01pm
424B5
kn8qq8lm
4 Apr 23
Prospectus supplement for primary offering
4:19pm
6-K
EX-99.1
42watcdp91luh2ua
4 Apr 23
Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
9:30am
6-K
EX-99.1
5cyexvsft8koky95 45
27 Dec 22
Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
9:11am
6-K
EX-99.1
y83blmmhyimwwmlyhucz
20 Dec 22
InspiraTM Technologies Begins Manufacturing of the ALICETM CPB Device, ahead of planned 2023 FDA submission
4:27pm
6-K
EX-99.1
cznhfr 1qh
14 Dec 22
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLATM Blood Sensor
8:52am
6-K
EX-99.1
rxzzfjfscr
22 Nov 22
The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals
9:18am
POS AM
i48dlbvpmtdswq6ixwx5
13 Oct 22
Prospectus update (post-effective amendment)
4:01pm
6-K
EX-99.2
c9ofra
29 Sep 22
Interim Condensed Financial Statements
2:33pm
F-3
cgpwpbfgsbmko
10 Aug 22
Shelf registration (foreign)
5:13pm
6-K
EX-99.1
khpoc3x0pnfz8 1v
8 Aug 22
Copyright © 2018 - 2022 Inspira Technologies OXY B.H.N. LTD., All rights reserved August 2022 Investor Presentation
9:17am
POS AM
ehpw3
14 Apr 22
Prospectus update (post-effective amendment)
4:40pm
20-F
yf60p96om vm3i
31 Mar 22
Annual report (foreign)
4:48pm
6-K
EX-99.2
qopkddltsq
31 Mar 22
Inspira Technologies Releases Q4 & FY2021 Financial Results
4:08pm
6-K
EX-99.1
rlh psyqm
1 Feb 22
Report of Foreign Private Issuer
8:58am
6-K
EX-99.1
8zte8
31 Jan 22
Inspira Technologies Signs a Strategic Agreement in the U.S. to
9:06am
6-K
EX-99.2
lyq0d
20 Dec 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
80crjmf
12 Nov 21
Notice of EXTRAORDINARY General Meeting of shareholders
6:02am